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This research work aims to develop glipizide tablets using 
Hibiscus rosasinensis leaves mucilage. The mucilage was 
extracted by using double distilled water and precipitated with 
ethanol. The precipitated mucilage was dried and grounded into 
powder. The tablet utilizing the mucilage as excipient was 
prepared by wet granulation method. The tablets were subjected 
to various tests. The evaluatory parameters of tablets were 
found to be within the limits as per United States Pharmacopoeia 
NF 24/19. FTIR spectrum reveals that there is no incompatibility 
between the ingredients used. Diabetes was induced in wistar 
albino rats using streptozotocin and effect of formulation on 
blood glucose level was determined. It was observed that the 
formulation could not sustain the release of glipizide. However, 
the glipizide release was retarded as the amount of mucilage was 
increased. It was observed that on the completion of antidiabetic 
study, the formulation could bring the blood glucose level to 
normal in group rats. However, the blood glucose level was still 
elevated in group administered with pure gliplizide. It can be 
concluded that HRM can be used to formulate glipizide tablets. 
The formulations with HRM shows better hypoglycemic activity 
and this may be attributed to antidiabetic activity of Hibiscus 
rosasinensis.  
 




The therapeutic efficacy and stability of 
any formulation not only depends on active 
pharmaceutical ingredients, but also on the 
excipients used and manufacturing process 
(Bahadur et al., 2014). Recently excipients from 
natural sources have gained tremendous 
interest amongst researchers. This may be 
attributed to number of advantages that 
excipients from natural sources have over 
excipients from synthetic or semi synthetic 
sources. Gums and mucilages are 
hydrocolloids. Gums are produced either by 
causing injury to the plants or due to some 
pathological condition. Mucilages are 
considered to be physiological and normal 
products of metabolism (Razavi et al., 2014). 
Naturally occurring mucilages are used 
extensively these days due to their 
biodegradable nature, safety, availability and 
economical. Deficiency of insulin secretion or 
inaction of insulin leads to a group of metabolic 
diseases, commonly known as diabetes. This 
leads to chronic hyperglycemia and causes long 
term damage to different organs (American 
Diabetes Association, 2014). According to 
International Diabetes Federation (IDF), 387 
million people have diabetes, which is expected 
to rise to 592 million by 2035. 90% of diabetics 
around the world are suffering from type 2 
diabetes (Media Centre, 2016). Oral anti-
diabetic agents can be administered for 
management of blood glucose level in type 2 
diabetes. Glipizide is extensively and widely 
used for management of glucose level in type 2 
diabetic patients. Glipizide is sulphonyl urea 
antidiabetic agents, having pKa 5.9, partially 
soluble in water and falls in class II category of 
drugs according to Biopharmaceutical 
Classification System (Kambham, Shanthi, 
2012). Hibiscus rosasinesis (HR) is commonly 
known as China rose. The roots are demulcent. 
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Leaves and flowers have anti ulcer activity and 
reported to promote growth and colour of hair. 
(Sankaran, 2011). Leaf extract of HR is 
reported to have antidiabetic activity (Moqbel, 
et al., 2011). The aim of this research work is to 
develop tablets of glipizide using HR mucilage 
(HRM) as binder.  
 
MATERIALS AND METHODS 
Glipizide was received as gift sample 
from Dishman Pharmaceuticals & Chemicals 
Ltd, Ahmedabad. Microcrystalline cellulose, 
Talc and Magnesium Stearate was procured 
from SD Fine Chemcials Ltd., India. All the 
other chemicals used were of analytical grades.  
 
Extraction of mucilage 
HR leaves was collected and washed 
carefully with double distilled water to remove 
any adherent material. The leaf was grinded 
with small amount of water using mixer grinder 
to form slurry. The slurry thus prepared was 
precipitated in about three times its volume of 
ethanol with continuous stirring with 
mechanical stirrer. The precipitate was washed 
for three times with ethanol and dried at 
40±1°C. The dried material was ground by a 
mechanical grinder and passed through # 60 
mesh sieve and kept in a desiccator till further 
use 
 
Preparation of tablets 
Eight different formulations (F1-F8) 
were prepared using different proportion of 
HRM (Table I) by using wet granulation 
method. HRM powder was sieved through 
sieve no. 22 separately and mixed with glipizide 
and microcrystalline cellulose. The mixture was 
granulated by using sufficient distilled water. 
The granules were dried in a tray drier at 50°C. 
The granules were passed through sieve no. 20 
and then lubricated using talc and magnesium 
stearate (1:1). The granules were compressed 
on 10 – station tablet compression machine 
(Shakti Machineries, India) using 10mm 
punches.    
 
Evaluation of prepared tablets 
Thickness  
The thickness of five tablets was 
determined using a verniar calliper and average 
was noted. 
Weight variation test  
20 tablets were weighed using electronic 
balance (Denver APX-100, Arvada, Colorado) 
and test was performed as per the official 
method of United States Pharmacopoeia (USP). 
 
Drug content  
Five tablets were weighed individually, 
and the drug was extracted in phosphate buffer 
pH 7.4. The absorbance of the extract was 
recorded by using UV – spectrophotometer 
(1800, Shimadzu, Japan) at 274nm. The 
concentration of drug extracted and then drug 
content was determined by using standard 
calibration curve.   
 
Hardness and Friability 
For each formulation, the hardness and 
friability of 5 and 20 tablets respectively, were 
determined using the Monsanto hardness tester 
(Cad-mach, Ahmedabad, India) and the Roche 
friabilator (Camp-bell Electronics, Mumbai, 
India). 
 
Drug polymer compatibility studies 
Drug polymer compatibility study was 
carried out using Infra red spectrophotometer 
(IR Affinity, Shimadzu, Tokyo, Japan). 
Prepared tablets were compressed with 
potassium  bromide  and transformed into disk.  
Table I. Composition of various glipizide tablet formulations 
 
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 
Glipizide (mg) 40 40 40 40 40 40 40 40 
HRM (mg) 40 60 80 100 120 140 160 200 
Microcrystalline cellulose (mg) 216 196 176 156 136 116 96 56 
Distilled water (ml) q.s q.s q.s q.s q.s q.s q.s q.s 
Talc (mg) 2 2 2 2 2 2 2 2 
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The disk was placed at the centre of sample 
holder and scanned between 4000-400cm–1 at 
resolution 4cm–1. The spectrum of formulation 
and glipizide was compared to determine drug 
polymer compatibility.  
 
In vitro release studies 
Release of glipizide from tablets was 
studied in USP Apparatus II (Veego, Kolkata, 
India), paddles at 100rpm and 37±0.5°C. 
Dissolution was carried out using Phosphate 
buffer pH 7.4 as dissolution medium. 5mL 
samples were withdrawn at every 5min and 
analyzed using UV spectrophotometer (UV – 
1800, Shimadzu, Japan) 274nm. Dissolution 
study was carried out in triplicate and average 
was considered.  
 
Effect on blood glucose level  
The animal study was approved by 
Institutional Animal Ethical Committee 
(CIP/IAEC/2015–16/070). Wistar albino rats 
(150-250g) were used for this study. Diabetes 
was induced in rats by a single intra peritoneal 
injection of streptozotocin at 60mg/kg body 
weight in freshly prepared citrate buffer pH 4.5. 
The animals were divided into four groups 
(n=6). Group I was treated as normal group, 
normally fed, neither diabetes induced nor 
treated. Group II, Diabetic control               
group treated only with vehicle. Group III, 
Treated with 5 mg/kg Glipizide administered 
orally and Group IV, Treated with formulation 
F4 containing 3mg/kg equivalent of          
glipizide 
 
Statistical analysis  
Data were statically evaluated by using 
one way ANOVA. Wherever the ANOVA 
values were found to be significant Duncan’s 
new multiple range test (DMRT) was applied 
(SPSS statistics software). The values were 
considered significant when P<0.05 
 
RESULT AND DISCUSSION  
Diabetes has taken a shape of endemic. 
World Health Organization in its global report 
in Diabetes reports that 1.5 millions deaths 
were caused by diabetes alone in 2014. The 
number of diabetics has increased to 422 
million in 2014 from 108 million in 1980 
(Media Centre , 2016). There are number of 
literatures which reveal the antidiabetic activity 
of HR leaves. The aim of this research work is 
to formulate and evaluate glipizide tablets 
containing HRM as binder. Glipizide tablet was 
formulated by wet variation method. Amount 
of HRM was varied in formulations. The 
prepared tablets were subjected various 
evaluation parameters.  
Average thickness of tablets varies from 
3.36±0.03 to 3.45±0.02mm. Deviation in weight 
variation test and friability is well within the 
permission limit of tablets as per USP. Average 
hardness of the tablet was found to be 5.0±0.14 
to 5.8±0.24 kg/cm2. Disintegration time was 
found to be from 4.24±0.12 to 5.76±0.22 min. 
Results of various parameters (Table II). 
Drug polymer compatibility was 
determined by comparing FTIR spectrum           
of       pure     glipizide      and      formulations.  
  


















F1 3.42±0.03 3.895±0.03 95.60±0.02 5.5±0.20 0.75±0.02 4.35±0.21 
F2 3.45±0.04 2.876±0.04 97.96±0.03 5.0±0.14 0.88±0.05 5.54±0.32 
F3 3.39±0.02 2.987±0.03 98.37±0.02 5.3±0.23 0.85±0.06 4.24±0.12 
F4 3.36±0.03 2.167±0.01 98.92±0.02 5.5±0.25 0.36±0.03 5.76±0.22 
F5 3.45±0.02 2.567±0.03 96.55±0.13 5.6±0.16 0.72±0.05 4.51±0.29 
F6 3.38±0.03 3.125±0.02 96.51±0.03 5.7±0.16 0.73±0.04 4.87±0.19 
F7 3.45±0.01 2.987±0.04 97.50±0.04 5.8±0.24 0.68±0.12 4.48±0.12 
F8 3.38±0.02 2.541±0.02 96.79±0.02 5.4±0.19 0.70±0.06 4.35±0.52 
 
* All values are expressed as mean ± SE, n = 5; † All values are expressed as mean ± SE, n = 20 
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The characteristic peaks of glipizide 1528, 
representing C-H stretching (aromatic), 1690, 
representing C=O amide, 1650, representing 
C=O urea, 1159, 1032, 900 cm−1, representing 
O=S=O (Moffat, et al., 2011) were observed 
both in pure glipizide sample and the 
formulations (Figure 1). This indicates that no 
chemical incompatibility between glipizide and 
the excipients used exists. 
In vitro drug release study was done using 
phosphate buffer pH 7.4. During this study, it 
was decided to check whether the formulation 
could sustain the release of drug. However, it 
was observed that the formulation could not 
sustain the release the drug. Then the samples 
were withdrawn in 5min interval for 90min  
and fresh phosphate buffer pH 7.4 was added 
to maintain the sink condition. The withdrawn 
sample was analyzed using UV spectro-
photometer at 274nm. The result of dissolution 
study (Figure 2). As the concentration of HRM 
was increased in the formulation, the release of 
glipizide from the formulation was reduced. F7 
& F8 containing higher amount of HRM, 
sustains the release of glipizide till 90min. 
However, based on results of all the 
physicochemical and in vitro release, F4 was 
selected for conducting antidiabetic study.  
Diabetes was induced by single intra 
peritoneal injection of streptozotocin at 
60mg/kg. Blood glucose level (Table III) of 
Group I was normal (83.20±2.24) on the day of 
commencement and remained normal 
throughout    the   completion   of  experiment. 
Group II was treated as diabetic control and 
didn’t receive any treatment. It exhibited 
hyperglycemia on the first day and continued to 
be hyperglycaemic throughout the study. 
 
 




Figure 2: In vitro release profile of formulations (F1 – F8)  
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Group III rats were administered with glipizide 
and blood glucose level was hyperglycaemic 
(309.54±5.44) on day one. However, it was 
reduced to non – diabetic levels on completion 
of experiment. Hyperglycemic status of Group 
IV rats was reduced to normal on completion 
of experiment. It was observed that the 
formulation, F4, was exhibiting promising 
result and could reduce elevated glucose level 
to lower levels than in Group III. Group IV 
animals were treated with lesser amount of 
glipizide than group III animals. However, 
group IV animal shows better glucose lowering 
activity compared to glipizide alone. This may 
be due to the fact that HR has antidiabetic 
activity as reported in many literatures and the 
mucilage extracted from HR may have acquired 
the antidiabetic property. This could have 
potentiated the activity of glipizide and thereby 
showing better results than the groups treated 
with glipizide alone.  
 
CONCLUSION  
It has been demonstrated in this study 
that HRM can be used as binder for 
formulation of glipizide tablets. The 
antidiabetic effect of formulation F4 reveals 
that the formulation exhibits better 
hypoglycaemic effect than the pure glipizide. 
This can be due to the fact that Hibiscus 
rosasinensis also possess antidiabetic activity. The 
mucilage may have some acquired 
hypoglycaemic activity that potentiated the 
activity. This calls for recognizing the dual role 
of mucilage, excipients & potentiating of 
antidiabetic activity. However, it is suggested 
that human studies with the mucilage and 
combinations   with   glipizide  must be     studied  
further. This may lead to development of useful 
formulation with lesser amount of oral 
hypoglycaemic agents and thereby better 
therapeutic applications and lesser side effects. 
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